Sanofi Pasteur Korea appoint new General Manager
July 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical
Sanofi Pasteur Korea has announced that Baptiste de Clarens will be the new General Manager of the unit, after the …
Breakthrough gene therapy shows promise in Duchenne muscular dystrophy
July 26, 2017Research and Development DMD, Duchenne Muscular Dystrophy, University of London, University of Nantes, biotech, drugs, pharma, pharmaceutical
New research, led by teams from AFM-Telethon laboratory in Nantes and the University of London, have developed a gene therapy …
Roche antibody becomes first of its kind authorised for blood cancer
July 26, 2017Research and Development, Sales and Marketing CDF, Cancer, NICE, drugs, lymphoma, pharma, pharmaceutical Roche
NICE has announced its decision to make Roche’s Gazyvaro available via the Cancer Drugs Fund (CDF) in combination with chemotherapy …
Janssen single tablet regimen shows Phase 3 success in HIV
July 26, 2017Research and Development HIV, Janssen, biotech, healthcare, pharma, pharmaceuticals
The latest Phase 3 data investigating Janssen’s darunivir in the treatment of human immunodeficiency virus (HIV-1) showed that the drug …
Celgene agrees one of the largest settlements for false claims on record
July 26, 2017Research and Development, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical, thalomid
It has been announced that Celgene has agreed to settle a case after a whistle-blower launched a lawsuit against the …
Further evidence of NHS recruitment crisis as vacancies skyrocket
July 25, 2017Medical Communications, Research and Development NHS, biotech, drugs, midwifery, nursing, pharma, pharmaceutical
Data released by NHS Digital rings a very worn bell regarding levels of staff employed and recruited the NHS, as …
MSD’s Keytruda hits rare snag, floundering in confirmatory trial
July 25, 2017Manufacturing and Production, Sales and Marketing MSD, Merck, biotech, drugs, keytruda, pharma, pharmaceutical
Since the PD-1/PD-L1 immunotherapies have hit the market, they have revolutionised cancer care for many patients yet, with the science …
FDA Chief plans regulatory overhaul to tackle US opioid crisis
July 25, 2017Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb, biotech, drugs, healthcare, opioid, pharma, pharmaceutical
The US faces an ongoing crisis in opioid dependency, and FDA Commissioner Scott Gottlieb is prepared to employ unusual tactics …
China’s distribution changes force major US company out
July 25, 2017Manufacturing and Production, Sales and Marketing Cardinal Health, China, biotech, distribution, drugs, pharma, pharmaceutical
Cardinal Health, one of the largest drug distributors in the US, is looking to sell on its network in China, …
Lilly snaps up autoimmune drug in $400m biotech partnership
July 25, 2017Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, Nektar, aceutical, biotech, drugs, healthcare, phar, pharma
Eli Lilly is to enter a partnership with Nektar Therapeutics to tap into the biotech’s new autoimmune disease therapy as …
Endo pulls plug on Alabama plant, 875 jobs lost
July 25, 2017Manufacturing and Production Endo, Qualitest, biotech, drugs, generics, pharma, pharmaceutical
Endo International has announced that it will close down its manufacturing and distribution facilities in Huntsville, Alabama, as part of …
Context Therapeutics add new CMO
July 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Context Therapeutics, biotech, drugs, pharma, pharmaceutical
Context Therapeutics, a biotech company that focuses on the development of treatments for Sigma1-related diseases, has announced that a new …
NHS England takes tough stance on homeopathy
July 24, 2017Sales and Marketing NHS England, biotech, drugs, pharma, pharmaceutical
Homeopathy is one of the most controversial subjects within the healthcare system and NHS England has outlined its stance by …
Wave expands editorial and programme delivery teams with two appointments
July 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, healthcare, pharma, pharmaceutical
Specialist medical education company, Wave, has boosted its editorial and programme delivery teams with two new appointments. Sadaf Kazi joins …
The British Pharmacopoeia 2018 now available
July 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Pharmacopoeia, biotech, drugs, healthcare, pharma, pharmaceutical
The British Pharmacopoeia (BP) 2018 is now published and available for purchase. An essential text for anyone working to develop …
Monthly injectable HIV treatment proves as effective as traditional daily pill regimen
July 24, 2017Research and Development, Sales and Marketing AIDS, HIV, Janssen, ViiV Healthcare, biotech, drugs, pharma, pharmaceuticals
New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication …
Over 3% of all drugs in Indian market not up to standard
July 24, 2017Manufacturing and Production, Sales and Marketing India, biotech, drugs, pharma, pharmaceutical
The Central Drugs Standard Control Organisation (CDSCO) tested drugs to determine whether they were of standard quality but found that …
Teva to cut over 300 production jobs in Israel
July 24, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, generics, healthcare, pharma, pharmaceutical
Teva, one of the world’s biggest generics firms and the biggest company in Israel, has revealed it plans to slash …
$1.1 billion swoop for promising Parkinson’s drug developer
July 24, 2017Sales and Marketing Mitsubishi Tanabe Pharma Corporation, Neuroderm, biotech, drugs, pharma, pharmaceutical
Mitsubishi Tanabe Pharma Corporation (MTPC) has announced that it has moved to acquire Israeli pharma company, NeuroDerm, in a deal …
GSK unveil appointment coup for board of directors
July 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, GSK, biotech, drugs, immunooncology, pharma, pharmaceutical
GSK continue its appointment spree with a particularly notable staff acquisition, with leading immuno-oncology scientist, Dr Laurie Glimcher, joining its …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
